High tumor cell Ang-2 expression alone had no prognostic survival impact, but when co-expressed with a high rather than low VEGF-A level, this combination led to a significantly worse 5-year survival (32%) with an HR at 6.43. The gene discussed is VEGFA; the disease is neoplasm.